CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients
- PMID: 22096627
- PMCID: PMC3195283
- DOI: 10.1155/2011/153282
CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients
Abstract
Multiple sclerosis (MS) disease is carried through inflammatory and degenerative stages. Based on clinical feaures, it can be subdivided into three groups: relapsing-remitting MS, secondary progressive MS, and primary progressive MS. Multiple sclerosis has a multifactorial etiology with an interplay of genetic predisposition, environmental factors, and autoimmune inflammatory mechanism in which play a key role CC-chemokines and its receptors. In this paper, we studied the frequency of CCR5 gene Δ32 allele in a cohort of Sicilian RR-MS patients comparing with general Sicilian population. Also, we evaluate the association between this commonly polymorphism and disability development and age of disease onset in the same cohort. Our results show that presence of CCR5Δ32 is significantly associated with expanded disability status scale score (EDSS) but not with age of disease onset.
References
-
- Bosnjak-Pasić M, Vidrih B, Miskov S, Demarin V. Treatment of multiple sclerosis. Acta Clinica Croatica. 2009;48(3):349–353. - PubMed
-
- Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221–1231. - PubMed
-
- Hansen T, Skytthe A, Stenager E, Petersen HC, Brønnum-Hansen H, Kyvik KO. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Multiple Sclerosis. 2005;11(5):504–510. - PubMed
-
- Yan J, Greer JM. NF-κB, a potential therapeutic target for the treatment of multiple sclerosis. CNS and Neurological Disorders. 2008;7(6):536–557. - PubMed
LinkOut - more resources
Full Text Sources
